Retina Implant’s Founder Awarded the...

Home » The Institute » News & Events » News » News Article

Retina Implant’s Founder Awarded the Saudi Ophthalmological Society Gold Medal Lecture Award

Professor Eberhart Zrenner, founder and lead clinical trial investigator and founding director of the Institute of Ophthalmic Research, University of Tuebingen, Germany was awarded the Saudi Ophthalmological Society Gold Medal Lecture award at the Saudi Ophthalmology 2015 annual meeting in Riyadh.

Professor Eberhart Zrenner honored with the Gold Medal for his Presentation on the Artificial Vision Industry at Saudi Ophthalmology 2015 Conference

The award, presented by HRH Prince Abdulaziz Al-Saud, was given in recognition of Professor Zrenner’s presentation on the state of the artificial vision development  on 2 March 2015. The award recognizes the tremendous advancements in artificial vision documented in Professor Zrenner’s presentation, which is a testament to his contributions and dedication to the improvement of ophthalmology and ophthalmic care.

The presentation titled, “The Various Electronic Implants For Blind Patients Presently Available & Under Development” was delivered on 3 March and discussed the use of retinal implants, including Retina Implant’s Alpha IMS subretinal microchip, to restore partial vision to patients blinded by retinitis pigmentosa (RP). Professor Zrenner also presented four additional lectures on topics including retinal implants and the OkuStim transcorneal electrical stimulation therapy.

Speaking of the award, Professor Zrenner said, “It is an incredible honor to be presented this prestigious award by HRH Prince Abdulaziz. I accept this award on behalf of the entire research team who are an integral part of the progress we have made and shared at this conference. We have long strived for a treatment that restores vision to RP patients and it is gratifying that the day we have been working towards for more than a decade is finally upon us.”

“Being the sole recipient of the Gold Medal Lecture award was quite an honor,” said Walter-G Wrobel, CEO of Retina Implant AG. “Sharing our key learnings at the Saudi Ophthalmology conference and receiving this award validates the significant contributions our talented clinical team has made in the treatment of retinal degeneration.”

The Saudi Ophthalmology 2015 Conference is the combined meeting of the 32nd Annual Symposium of the King Khaled Eye Specialist Hospital and the 27th Annual Scientific Meeting of the Saudi Ophthalmological Society, in collaboration with the Ophthalmology Department, College of Medicine, King Saud University. This conference took place at the King Fahd Cultural Center, Riyadh, Saudi Arabia, from 2-5 March. The conference focuses on recent advances in the following fields of ophthalmology: cataract, cornea, refractive surgery, glaucoma, pathology, oculoplastics, prevention of blindness, optometry and retina. Saudi Ophthalmology strives to update participants on the latest developments in ophthalmology techniques and equipment, share expertise from renowned international guest speakers and educate participants to provide a higher level of ophthalmic care.